🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 13 of 78

  1. US 11091509

    HPPK inhibitors useful as antibacterial agents

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11090313

    Methods for inhibiting muscle atrophy

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11084856

    Interleukin-4 receptor-binding fusion proteins and uses thereof

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11083775

    Transgenic corn with antifungal peptide AGM182 USDA (DN:0113.18)

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11084850

    Recombinant prefusion RSV F proteins and uses thereof

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11083801

    Factor VIII mutation repair and tolerance induction

    Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11077182

    Methods of preparing anti-human papillomavirus antigen T cells

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11077200

    Combined enteropathogen recombinant construct

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11078239

    Prefusion PIV F immunogens and their use

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11078286

    Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11077178

    Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11072606

    Compositions and methods for treating diseases and conditions

    Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11065327

    Human rotavirus strains and vaccines

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11066674

    Chimeric antigen receptors targeting b-cell maturation antigen

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11066479

    Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11066371

    Pyridine compound, making, and use thereof

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11065254

    Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11065332

    Combination therapy of immunotoxin and checkpoint inhibitor

    Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11058729

    Exosomes and miRNA to treat glaucoma

    Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11060110

    Adeno-associated virus vectors for treatment of glycogen storage disease

    Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11059808

    Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV

    Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11058770

    Ultrastable antibody ionic liquids

    Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11053290

    Modified Tamm-Horsfall protein and related compositions and methods of use

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11053285

    Nucleic acids encoding human immunodeficiency virus type 1 (HIV-1) N-terminal deleted gp120 immunogens and methods of use

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11053314

    Methods to eliminate cancer stem cells by targeting CD47

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11052057

    Use of cysteamine and derivatives thereof to suppress tumor metastases

    Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11045558

    RPGR gene therapy for retinitis pigmentosa

    Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11041008

    Heterodimers of IL-15 and IL-15R alpha to increase thymic output and to treat lymphopenia

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11041170

    Multivalent vaccines for rabies virus and coronaviruses

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11040019

    Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11040935

    Small molecule AMPK activators

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11040082

    Compositions and methods for treating colorectal cancer

    Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11034757

    Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculature

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11034740

    Brachyury deletion mutants, non-yeast vectors encoding Brachyury deletion mutants, and their use

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11033505

    Oral complex preparation comprising fat-soluble drug and solid preparation coated with oil-proof material

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11033620

    Combination therapies targeting tumor-associated stroma or tumor cells and microtubules

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11034736

    Anti-viral cnidarins

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11033621

    Combination therapies targeting tumor-associated stroma or tumor cells

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11033554

    Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11033615

    Zika virus vaccine and methods of production

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11028444

    Survival predictor for diffuse large B cell lymphoma

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11028152

    Single domain antibodies to Chikungunya virus

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11028079

    Small molecule BET bromodomain inhibitors and uses thereof

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11027008

    Recombinant mumps virus vaccine

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11026947

    ALK2 inhibitors and methods for inhibiting BMP signaling

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11027007

    Recombinant metapneumovirus F proteins and their use

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11020510

    Muscle cell patches and uses therefor

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11021535

    Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use

    Expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.